A brief description of the instructions for use of the Laos Lucius version of crizotinib generic drug

Crizotinib is a targeted anti-tumor drug mainly used to treat patients with anaplastic lymphoma kinase (ALK)-positive or ROS1-positive locally advanced or metastatic non-small cell lung cancer. The drug achieves its therapeutic purpose by inhibiting specific tyrosine kinase receptors and blocking the proliferation and survival of tumor cells. With the development of medical globalization, more and more patients are paying attention to overseas generic drugs. Among them, the Laos Lucius version of crizotinib has attracted much attention as an affordable option. This article will provide a brief overview of the instructions for use of the Laos Lucius version of the generic crizotinib to help patients better understand and use the drug.

1. Basic information

The specifications of the Laos Lucius version are250mg*60 tablets, and the price is about more than 1,000 yuan. This version has been approved by the government and is a regular drug approved by the Lao Ministry of Health for marketing, and its quality is guaranteed.

2. Usage and dosage

1. Metastatic non-small cell lung cancer or unresectableIMT: The recommended dose of Laos Lucius version of crizotinib is 250 mg orally administered twice daily.

2. Lymphoma or unresectableIMT: The common pediatric dose is 280 mg/m², taken orally twice a day.

3. Patients can choose to take the medication on an empty stomach or with food, but should ensure that each dose is taken at approximately the same time. Capsules should be swallowed whole and not chewed or crushed. If the patient misses a dose and it is more than 6 hours before the next dose, the patient should take it as soon as possible; if it is less than 6 hours, there is no need to take the dose again and the next dose can be taken at the normal time.

3. Precautions

1. Liver function monitoring: Crizotinib is mainly metabolized in the liver and should be used with caution in patients with liver damage. It is recommended to check liver function every two weeks at the beginning of treatment and monthly thereafter, and adjust the dose if necessary.

2. Vision and heart monitoring: Some patients may experience adverse reactions such as blurred vision and bradycardia after taking crizotinib. Therefore, patients should undergo regular vision examinations and electrocardiogram monitoring to ensure the safety of medication.

3. Fertility and lactation: Crizotinib may cause decreased fertility. Patients who plan to have children are advised to take contraceptive measures during treatment and for a period of time after stopping the drug. At the same time, lactating women should avoid breastfeeding during treatment and within 45 days after stopping the drug.

4. Drug interactions: crizotinib and certain drugs (such asThe combined use of strong CYP3A inhibitors or inducers) may affect drug efficacy or increase the risk of side effects. Therefore, patients should inform their doctors about all medications they are taking before taking them to avoid drug-drug interactions.

In short, the Laos Lucius version of crizotinib, as one of the important generic drugs for the treatment of non-small cell lung cancer, provides patients with more treatment options. However, patients should strictly abide by medical instructions and instructions during use to ensure the safety and effectiveness of the medication. At the same time, regular monitoring of relevant indicators and adverse reactions is also an important part of ensuring the effectiveness of treatment.